Cargando…
Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients
BACKGROUND: Barriers and facilitators to physical activity in inflammatory arthritis can be assessed through the Inflammatory arthritis FAcilitators and Barriers (IFAB) questionnaire. The objective was to measure the correlation between IFAB and self-reported physical activity levels. METHODS: This...
Autores principales: | Davergne, Thomas, Tekaya, Rawdha, Sellam, Jérémie, Tournadre, Anne, Mitrovic, Stéphane, Ruyssen-Witrand, Adeline, Hudry, Christophe, Dadoun, Sabrina, Avouac, Jérôme, Fautrel, Bruno, Gossec, Laure |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556961/ https://www.ncbi.nlm.nih.gov/pubmed/34717606 http://dx.doi.org/10.1186/s12891-021-04792-7 |
Ejemplares similares
-
Physical Activity Assessment Using an Activity Tracker in Patients with Rheumatoid Arthritis and Axial Spondyloarthritis: Prospective Observational Study
por: Jacquemin, Charlotte, et al.
Publicado: (2018) -
Flares assessed weekly in patients with rheumatoid arthritis or axial spondyloarthritis and relationship with physical activity measured using a connected activity tracker: a 3-month study
por: Jacquemin, Charlotte, et al.
Publicado: (2017) -
Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years
por: Lucasson, Florian, et al.
Publicado: (2022) -
Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain
por: Puyraimond-Zemmour, Déborah, et al.
Publicado: (2019) -
Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France
por: Dougados, Maxime, et al.
Publicado: (2022)